EDAP TMS S.A Debt to Equity Ratio 2011-2025 | EDAP
Current and historical debt to equity ratio values for EDAP TMS S.A (EDAP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. EDAP TMS S.A debt/equity for the three months ending June 30, 2025 was 0.04.
| EDAP TMS S.A Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $0.05B | $0.03B | 1.46 |
| 2025-03-31 | $0.04B | $0.04B | 1.18 |
| 2024-12-31 | $0.05B | $0.04B | 1.10 |
| 2024-09-30 | $0.04B | $0.05B | 0.85 |
| 2024-06-30 | $0.04B | $0.05B | 0.73 |
| 2024-03-31 | $0.04B | $0.06B | 0.68 |
| 2023-12-31 | $0.04B | $0.06B | 0.61 |
| 2023-09-30 | $0.04B | $0.06B | 0.55 |
| 2023-06-30 | $0.04B | $0.07B | 0.51 |
| 2023-03-31 | $0.04B | $0.07B | 0.51 |
| 2022-12-31 | $0.03B | $0.08B | 0.41 |
| 2022-09-30 | $0.03B | $0.07B | 0.41 |
| 2022-06-30 | $0.03B | $0.06B | 0.56 |
| 2022-03-31 | $0.03B | $0.06B | 0.51 |
| 2021-12-31 | $0.03B | $0.06B | 0.54 |
| 2021-09-30 | $0.03B | $0.06B | 0.53 |
| 2021-06-30 | $0.03B | $0.06B | 0.55 |
| 2021-03-31 | $0.03B | $0.03B | 0.99 |
| 2020-12-31 | $0.04B | $0.03B | 1.10 |
| 2020-09-30 | $0.03B | $0.03B | 1.05 |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.03B | $0.03B | 0.94 |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.03B | $0.03B | 0.95 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.03B | $0.03B | 0.90 |
| 2018-03-31 | $0.00B | 0.00 | |
| 2017-12-31 | $0.03B | $0.03B | 0.86 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.02B | $0.03B | 0.80 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.03B | $0.03B | 0.91 |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.03B | $0.03B | 0.92 |
| 2016-03-31 | $0.00B | 0.00 | |
| 2015-12-31 | $0.03B | $0.02B | 1.67 |
| 2015-09-30 | $0.00B | $0.00B | 0.00 |
| 2015-06-30 | $0.02B | $0.02B | 1.53 |
| 2015-03-31 | $0.00B | $0.00B | 0.00 |
| 2014-12-31 | $0.02B | $0.02B | 1.12 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.03B | $0.02B | 1.89 |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.02B | $0.01B | 1.90 |
| 2013-09-30 | $0.00B | 0.00 | |
| 2013-06-30 | $0.02B | $0.01B | 1.72 |
| 2013-03-31 | $0.02B | $0.01B | 2.94 |
| 2012-12-31 | $0.03B | $0.01B | 2.73 |
| 2012-09-30 | $0.02B | $0.01B | 1.47 |
| 2012-06-30 | $0.02B | $0.02B | 1.12 |
| 2012-03-31 | $0.02B | $0.02B | 1.01 |
| 2011-12-31 | $0.03B | $0.01B | 2.70 |
| 2011-09-30 | $0.02B | $0.01B | 1.34 |
| 2011-06-30 | $0.03B | $0.01B | 2.55 |
| 2011-03-31 | $0.02B | $0.01B | 1.42 |
| 2010-12-31 | $0.04B | $0.01B | 3.04 |
| 2010-09-30 | $0.02B | $0.01B | 1.44 |
| 2010-06-30 | $0.04B | $0.01B | 2.77 |
| 2010-03-31 | $0.02B | $0.02B | 1.18 |
| 2009-12-31 | $0.04B | $0.02B | 2.21 |
| 2009-09-30 | $0.02B | $0.02B | 1.15 |
| 2009-06-30 | $0.04B | $0.02B | 1.83 |
| 2009-03-31 | $0.02B | $0.02B | 1.03 |
| 2008-12-31 | $0.04B | $0.03B | 1.55 |
| 2008-09-30 | $0.02B | $0.02B | 0.94 |
| 2008-06-30 | $0.04B | $0.03B | 1.36 |
| 2008-03-31 | $0.02B | $0.03B | 0.72 |
| 2007-12-31 | $0.04B | $0.02B | 2.11 |
| 2007-09-30 | $0.02B | $0.02B | 0.94 |
| 2007-06-30 | $0.02B | $0.02B | 0.66 |
| 2007-03-31 | $0.02B | $0.02B | 0.62 |
| 2006-12-31 | $0.02B | $0.02B | 0.68 |
| 2006-09-30 | $0.02B | $0.03B | 0.58 |
| 2006-06-30 | $0.02B | $0.02B | 0.76 |
| 2006-03-31 | $0.01B | $0.02B | 0.57 |
| 2005-12-31 | $0.01B | $0.02B | 0.66 |
| 2005-09-30 | $0.00B | 0.00 | |
| 2005-06-30 | $0.00B | 0.00 | |
| 2005-03-31 | $0.00B | 0.00 | |
| 2004-12-31 | $0.01B | $0.02B | 0.55 |
| 2004-09-30 | $0.00B | 0.00 | |
| 2004-06-30 | $0.00B | 0.00 | |
| 2004-03-31 | $0.00B | 0.00 | |
| 2003-12-31 | $0.02B | $0.02B | 0.68 |
| 2003-09-30 | $0.00B | 0.00 | |
| 2003-06-30 | $0.00B | 0.00 | |
| 2003-03-31 | $0.00B | 0.00 | |
| 2002-12-31 | $0.01B | $0.03B | 0.40 |
| 2002-09-30 | $0.01B | $0.03B | 0.32 |
| 2002-06-30 | $0.01B | $0.03B | 0.33 |
| 2002-03-31 | $0.01B | $0.03B | 0.29 |
| 2001-12-31 | $0.01B | $0.03B | 0.37 |
| 2001-03-31 | $0.00B | 0.00 | |
| 2000-12-31 | $0.02B | $0.03B | 0.45 |
| 2000-09-30 | $0.00B | 0.00 | |
| 2000-06-30 | $0.00B | 0.00 | |
| 2000-03-31 | $0.00B | 0.00 | |
| 1999-12-31 | $0.02B | $0.02B | 1.36 |
| 1999-09-30 | $0.00B | 0.00 | |
| 1999-06-30 | $0.00B | 0.00 | |
| 1999-03-31 | $0.00B | 0.00 | |
| 1998-12-31 | $0.02B | $0.02B | 1.01 |
| 1998-09-30 | $0.00B | 0.00 | |
| 1998-06-30 | $0.00B | 0.00 | |
| 1998-03-31 | $0.00B | 0.00 | |
| 1997-12-31 | $0.00B | 0.00 | |
| 1997-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.079B | $0.069B |
| EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $217.426B | 25.84 |
| Intuitive Surgical (ISRG) | United States | $196.987B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.662B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.588B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.25 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |